ATE415973T1 - Gemeinsame gabe von tigecyclin und digoxin - Google Patents

Gemeinsame gabe von tigecyclin und digoxin

Info

Publication number
ATE415973T1
ATE415973T1 AT05851251T AT05851251T ATE415973T1 AT E415973 T1 ATE415973 T1 AT E415973T1 AT 05851251 T AT05851251 T AT 05851251T AT 05851251 T AT05851251 T AT 05851251T AT E415973 T1 ATE415973 T1 AT E415973T1
Authority
AT
Austria
Prior art keywords
tigecycline
digoxin
joint administration
administration
joint
Prior art date
Application number
AT05851251T
Other languages
English (en)
Inventor
Donald Raible
Gopal Muralidharan
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE415973T1 publication Critical patent/ATE415973T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
AT05851251T 2004-10-28 2005-10-24 Gemeinsame gabe von tigecyclin und digoxin ATE415973T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62285904P 2004-10-28 2004-10-28

Publications (1)

Publication Number Publication Date
ATE415973T1 true ATE415973T1 (de) 2008-12-15

Family

ID=36127476

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05851251T ATE415973T1 (de) 2004-10-28 2005-10-24 Gemeinsame gabe von tigecyclin und digoxin

Country Status (18)

Country Link
US (1) US20060094668A1 (de)
EP (1) EP1804807B1 (de)
JP (1) JP2008518911A (de)
KR (1) KR20070069182A (de)
CN (1) CN101039679A (de)
AT (1) ATE415973T1 (de)
AU (1) AU2005310306A1 (de)
BR (1) BRPI0517406A (de)
CA (1) CA2582089A1 (de)
CR (1) CR9073A (de)
DE (1) DE602005011468D1 (de)
EC (1) ECSP077423A (de)
IL (1) IL182681A0 (de)
MX (1) MX2007005163A (de)
NO (1) NO20071706L (de)
RU (1) RU2007112409A (de)
WO (1) WO2006060084A2 (de)
ZA (1) ZA200703441B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7879828B2 (en) 2005-03-14 2011-02-01 Wyeth Llc Tigecycline compositions and methods of preparation
AR055336A1 (es) * 2005-06-16 2007-08-22 Wyeth Corp Proeso de elaboracion para la produccion de tigeciclina como un polvo reconstituible, polvo de tigeciclina liofilizado y producto hecho mediante el proceso
GB2461037A (en) * 2008-06-17 2009-12-23 Elias Bouras A method of treating alopecia using a composition comprising a cardiac glycoside
US20100035845A1 (en) * 2008-08-06 2010-02-11 Wyeth Tigecycline formulations
CN110769826A (zh) 2017-01-27 2020-02-07 纽罗克里生物科学有限公司 施用某些vmat2抑制剂的方法
MA50175A (fr) 2017-09-21 2021-04-21 Neurocrine Biosciences Inc Formulation de valbenazine à dosage élevé et compositions, procédés et kits associés
CN111836543A (zh) 2017-10-10 2020-10-27 纽罗克里生物科学有限公司 施用某些vmat2抑制剂的方法

Also Published As

Publication number Publication date
DE602005011468D1 (de) 2009-01-15
EP1804807B1 (de) 2008-12-03
KR20070069182A (ko) 2007-07-02
BRPI0517406A (pt) 2008-10-07
ZA200703441B (en) 2008-09-25
NO20071706L (no) 2007-05-24
CR9073A (es) 2007-08-28
WO2006060084A3 (en) 2006-07-20
CA2582089A1 (en) 2006-06-08
WO2006060084A2 (en) 2006-06-08
US20060094668A1 (en) 2006-05-04
CN101039679A (zh) 2007-09-19
RU2007112409A (ru) 2008-12-10
IL182681A0 (en) 2007-09-20
MX2007005163A (es) 2007-06-26
ECSP077423A (es) 2007-05-30
AU2005310306A1 (en) 2006-06-08
JP2008518911A (ja) 2008-06-05
EP1804807A2 (de) 2007-07-11

Similar Documents

Publication Publication Date Title
ATE415973T1 (de) Gemeinsame gabe von tigecyclin und digoxin
CY1124135T1 (el) Δοσολογικα σχηματα για την αγωγη της νοσου ρομρε
ME00425B (me) Liječenje sa anti-vegf antitijelima
ATE531365T1 (de) Kombinationen und modi zur verabreichung therapeutischer mittel und kombinationstherapie
UY31305A1 (es) Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmacéuticas que las contienen.
AR087003A1 (es) Dispositivo separador modular para el tratamiento de infecciones de la protesis de miembros humanos
ATE477805T1 (de) 9a-carbamoyl-y-aminopropyl- und 9a-thiocarbamoyl- y-aminopropyl-azalide mit antimalaria-aktivität
CY1110182T1 (el) Ιδεβενονη για τη θεραπεια των μυϊκων δυστροφιων
GT200500266A (es) Nuevos derivados de pirimidina y su uso
EA201171186A1 (ru) Сокристалл этравирина и никотинамида
BR112018014302A2 (pt) derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano
CY1112121T1 (el) ΠΑΡΑΓΩΓΑ ΤΩΝ 1,2,3,4-ΤΕΤΡΑΫΔΡΟΠΥΡΡΟΛΟ-[1,2-α]-ΠΥΡΑΖΙΝ-6-ΚΑΡΒΟΞΑΜΙΔΙΩΝ ΚΑΙ ΤΩΝ 2,3,4,5-ΤΕΤΡΑΫΔΡΟΠΥΡΡΟΛΟ-(1,2-α)-ΔΙΑΖΕΠΙΝ-7-ΚΑΡΒΟΞΑΜΙΔΙΩΝ, Η ΠΑΡΑΣΚΕΥΗ ΤΟΥΣ ΚΑΙ Η ΕΦΑΡΜΟΓΗ ΤΟΥΣ ΣΕ ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ
ATE433459T1 (de) Desoxo-nonadepsipeptide
DE602004015487D1 (de) Programmiergerät für medizinisches gerät mit infrarot-kommunikation
UY28202A1 (es) Utilización de esteroides en el tratamiento de personas que sufren trastonos oculares.
EA200400197A1 (ru) Способы получения поливалентных бактериофагов для лечения бактериальных инфекций
IT1396915B1 (it) Dietil-[6-(4-idrossicarbamoil-fenil-carbamoilossimetil)-naftalen-2-il-metil]-ammonio cloruro ed altri derivati della n-idrossi-benzammide per l'uso nel trattamento di infezioni da hiv.
CO2023007851A2 (es) Proteínas de unión a il-7 y su uso en tratamientos médicos
EA200801890A1 (ru) Средство для лечения шума в ушах
WO2011106378A3 (en) Oral b12 therapy
NO20080495L (no) PEG-IFN-alfa og ribavirin for HBV-behandling
RU2010140179A (ru) Способ лечения пародонтита - способ иорданишвили
ZA202300222B (en) Anti-αlpha-4-βeta-7 antibodies
UA125457U (uk) Спосіб лікування хворих на герпетичний стоматит
RU2007136579A (ru) Способ лечения вич-инфицированных больных

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties